Helicobacter pylori: A new cardiovascuar risk factor?
Author
dc.contributor.author
Martínez Torres, Alejandra
Author
dc.contributor.author
Martínez Gaensly, Miguel
Admission date
dc.date.accessioned
2019-01-29T17:50:54Z
Available date
dc.date.available
2019-01-29T17:50:54Z
Publication date
dc.date.issued
2002
Cita de ítem
dc.identifier.citation
Revista Espanola de Cardiologia, Volumen 55, Issue 6, 2018, Pages 652-656
Identifier
dc.identifier.issn
03008932
Identifier
dc.identifier.other
10.1016/S0300-8932(02)76673-6
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/163459
Abstract
dc.description.abstract
There is increasing evidence that certain microbial agents may have an etiopathogenic role in the development of atherothrombosis. Helicobacter pylori, a bacterium that causes peptic ulcer disease, has been suggested as one of the microbes involved in the development of atherothrombosis. This hypothesis is based on the following observations: a) a higher prevalence of Helicobacter pylori infection in patients with coronary artery disease, myocardial infarction, or cerebrovascular disease; b) the coincidence of Helicobacter pylori infection and cardiovascular risk factors, such as serum cholesterol and triglyceride concentrations and plasma fibrinogen; c) Helicobacter pylori seropositivity correlates with acute-phase proteins associated with higher risk of coronary disease, such as C-reactive protein, and d) controversial PCR studies indicating the presence of Helicobacter pylori in atheromas. Analysis of the scientific evidence suggests that Helicobacter pylori infection could indirect